Hims & Hers Health (NYSE:HIMS) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 36.17 percent. This is a 81.25 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $598.976 million which beat the analyst consensus estimate of $580.241 million by 3.23 percent. This is a 49.16 percent increase over sales of $401.556 million the same period last year.